Current Research Studies
SC-N189: SUpporting Medication Management with Individualized Treatment (SUMMIT) for Adolescents and Young Adults with Cancer
SC-N189: SUMMIT Efficacy Trial (SUMMIT 2.0)
- Condition(s): Myeloid and Monocytic Leukemia, Unknown Sites, Bones and Joints, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Ill-Defined Sites, Brain and Nervous System, Leukemia, other, Soft Tissue, Thyroid, Lymphoid Leukemia
- Phase: N/A
- Clinicaltrials.gov ID: NCT07223463
What is the goal of the study?
This is a randomized clinical trial to evaluate the efficacy of a tailored adherence-promotion intervention on medication adherence, quality of life, and outpatient encounters among adolescents and young adults with cancer.
Who can participate in the study?
Please contact the study team listed below to learn more.
Study Team:
- PI (Study Doctor): Tyler Ketterl
- Study Team Member: HemOnc CRAs, [email protected]